The trefoil peptides, a recently recognized family of protease-resistant peptides, expressed in a regional specific pattern throughout the normal gastrointestinal tract. Although these peptides have been hypothesized to act as growth factors, their functional properties are largely unknown. Addition of recombinant trefoil peptides human spasmolytic polypeptide (HSP), rat and human intestinal trefoil factor (RITF and HITF) to subconfluent nontransformed rat intestinal epithelial cell lines (IEC-6 and IEC-17), human colon cancer-derived cell lines (HT-29 and CaCO2) or nontransformed fibroblasts (NRK and BHK) had no significant effect on proliferation. However addition of the trefoil peptides to wounded monolayers of confluent IEC-6 cells in an in vitro model of epithelial restitution resulted in a 3-6-fold increase in the rate of epithelial migration into the wound. Stimulation of restitution by the trefoil peptide HSP was enhanced in a cooperative fashion by the addition of mucin glycoproteins purified from the colon or small intestine of either rat or man, achieving up to a 15-fold enhancement in restitution. No synergistic effect was observed by the addition of nonmucin glycoproteins. In contrast to cytokine stimulation of intestinal epithelial cell restitution which is mediated through enhanced TGF8 bioactivity, trefoil peptide, and trefoil peptide-mucin glycoprotein stimulation of restitution was not associated with alteration in concentrations of bioactive TGF-13 and was not affected by the presence of immunoneutralizing anti-TGFB antiserum. Collectively, these findings suggest that the trefoil peptides which are secreted onto the lumenal surface of the gastrointestinal tract may act in conjunction with the mucin glycoprotein products of goblet cells to promote reestablishment of mucosal integrity after injury through mechanisms distinct from those which may act at the basolateral pole of the epithelium. (J. Clin. Invest. 1994.94:376-383.)
Introduction
Over the past several years a family of small peptides expressed at various sites throughout the gastrointestinal tract and desig-nated trefoil factors have been identified through a range of approaches. The members of this family share an array of structural features including, most notably, a motif of six cysteine residues termed a trefoil or a P domain, which is distinct from those found in other peptide families. Noting the shared cysteine motif present in the first two members of this family to be identified, Thim (1) postulated that the six cysteine residues could contribute to the formation of three intrachain loops via the formation of disulfide bonds; the resultant predicted three looped structure prompted the trefoil (three leaf) designation. A recent nuclear magnetic resonance (NMR) analysis of one of the trefoil peptides supported the presence of a distinctive secondary structure consistent with the putative three intrachain loop formation (2) . Various members of the family identified in mammals include one or two P domains (3) (4) (5) . Amphibians have been found to express trefoil proteins with one to as many as four P domains (6) .
Members of the trefoil peptide family appear to be expressed in a regional specific fashion throughout the gastrointestinal tract in a manner which has been conserved through evolution. Thus pS2, a peptide which was first identified through its ectopic expression in many hormonally responsive breast carcinomas is normally expressed predominantly in gastric mucosa (7, 8) . The trefoil peptides containing two P domains (e.g., human and porcine spasmolytic polypeptides [HSP and PSP])' are found in the distal stomach and pancreas while intestinal trefoil factor (ITF) containing one P domain, is found in small and large intestinal mucosa from the duodenum to the rectum (4, 5, 9, 10) . The trefoil peptide family appears to be relatively ancient with homologues present in the amphibian stomach and skin (designated XSL) (6, (11) (12) (13) (14) . However regional specific factors appear to have been individually conserved; the overall homologies among trefoil peptides found at different sites in the gastrointestinal tract within a single species range from 35 to 45% (e.g., human ITF vs. human pS2 = 37% homology), while the corresponding trefoil factors from different species may be as much as 85% identical (e.g., human vs. rat ITF -82% identity) (9) .
Although the high degree of evolutionary conservation of trefoil peptides and their abundance suggest that these peptides subserve important functions, insights into their physiological actions have been limited ( 11) . Interestingly, increased expression of trefoil peptides has been observed in association with ulceration in the gastrointestinal tract and has been localized to a cell thought to contain growth regulatory peptides (15) (16) (17) . It has been suggested that they may serve as growth factors and one member has been reported to modestly stimulate prolifera- (18) . However, the abundance of these peptides in the mucosa contrasts with the relatively low concentrations of previously described "conventional" peptide growth factors which modulate proliferation through interaction with high affinity specific cell surface receptors. Early studies suggested that at least one member of the family, porcine spasmolytic polypeptide (PSP), could alter both gastric acid secretion and gastrointestinal tract motility but whether these reflect direct physiological functions remains unclear (19) (20) (21) .
Although it is possible that the trefoil peptides serve a systemic function, it is notable that these peptides appear to be produced by goblet cells in the small and large intestine and their counterparts in other areas of the gastrointestinal tract, which secrete them onto the lumenal mucosal surface, presumably in conjunction with mucin glycoproteins (9, 10) . It is therefore possible that these peptides exert their most important function at the lumenal-mucosal interface where they are most abundant, possibly contributing in some fashion to the integrity of mucosal surface continuity. Indeed, these peptides may be structurally well suited to survive in a functional state despite the inevitable exposure to the lumenal proteases present throughout the gastrointestinal tract. Jorgenson et al. (21 ) have directly demonstrated a high degree of resistance to protease digestion of PSP which they ascribed to a compact structure of the PSP molecule. Comparable protease resistance has also been observed for ITT (H. Kindon and D. K. Podolsky, manuscript in preparation). In the present study, we explore the effects of model trefoil peptides alone and in conjunction with mucin glycoproteins on the restitution of wounded intestinal epithelial monolayers. Although the trefoil peptides did not appear to alter proliferation of these cell lines, they acted in a synergistic fashion to enhance the rate of restitution through a pathway distinct from that utilized by cytokines present at the basolateral surface.
Methods
Materials. Recombinant HSP (rHSP) was produced in yeast and purified as previously described (22) . In the present study the nonglycosylated form of rHSP was used, though essentially equivalent results were observed with glycosylated rHSP. Recombinant rat and human ITF (RITF and HITF) were produced after cloning the corresponding full length cDNAs into a commercially available baculovirus vector (Maxbac; Invitrogen, Sunnydale, CA) and expressed in the Sf9 insect cell line (H. Kindon and D. K. Podolsky, manuscript in preparation); equivalence with the native protein was confirmed by Western blot and SDS-PAGE analysis using a previously characterized anti-FIT specific antisera (10) .
Mucin glycoproteins were purified from human colonic mucosa as previously reported (23, 24) ; mucin glycoproteins were purified and used without further chromatographic fractionation into individual species. Nonmucin glycoproteins from human and rat colonic mucosa were separated on Sepharose 4B from the mucin glycoproteins obtained for comparative studies by chromatography performed as previously reported (23, 24) . The nonmucin glycoproteins recovered in the included volume were exhaustively dialyzed against water and lyophilyzed. Mucin glycoproteins were also purified from colonic mucosa and small intestinal mucosa from Sprague-Dawley rats essentially by application of the same techniques as used by others (25) . In all instances, mucin glycoproteins were recovered after CsCl density centrifugation with a buoyant density of > 1.45 g/ml.
Porcine TGFf31 (26, 27) Migration of IEC-6 cells was assessed by blinded counting of the number of IEC-6 cells observed across the wound border expressed as the mean number of cells present across the wound border in a standardized length (2 mm) using photomicrographs taken at 10OX with an inverted microscope Nikon Diaphor TMS and a Nikon N6006 camera. Duplicate wells were used in each experiment and three wound areas per well were used to quantitate migration; data from a minimum of three separate experiments were used for the determination of the effects of various substances on restitution (interassay variation < 10%). Data are expressed as mean cell number across the standard wound edge unit ±SD.
Determination of latent and bioactive TGF/3. Latent and bioactive TGF/3 were determined by a bioassay measuring inhibition of proliferation (incorporation of radiolabeled thymidine) by subconfluent mink lung epithelial cells (MvlLu) as described elsewhere (32). Briefly, for the determination of total (latent and bioactive) TGF/3, samples were first activated by acidification with 0.15 N HCO for 60 min, followed by neutralization before assay for TGF-/3 bioactivity. Bioactive TGF/3 was determined using samples without prior acidification. MvlLu cells (1 x 105 cells/well in 24-well plates) were seeded in 0.2% FCS in DME; 5 h after seeding, test samples or varying concentrations of the standard porcine platelet TGFP31 were added and cells cultured for 24 h at 37°C.
[3H]thymidine (1.5 pCi/well) was added and the incubation was continued for an additional 4 h. Cells were then washed with PBS and fixed in methanol:acetic acid (3:1 vol/vol). Acid insoluble material including thymidine incorporated into DNA was solubilized by addition of 1 N NaOH and incorporated radioactivity determined in a liquid scintillation counter. Effects of trefoil factors on cell proliferation. Cells (IEC-6, LEC-17, HT-29, CaCO2, T84, LS180, NRK, BHK and AGS, [33] , all obtained from the ATCC) were seeded into 24-well plate (1-5 X I04 cells/well) in the presence of DME containing 5% FCS. When -50% confluent, cells were washed three times and then further cultured for 24 h in DME containing 0.1% FCS. Cultures were then supplemented with rHSP, RITF, HMT, HCGP, RCGP, RSIGP, or RGGP individually or in combination in concentrations ranging from 0.1-5 Itg/,ul as cited in the text. After 20 h at 37°C, [3H]thymidine (1.8 .Ci/well; 1 yCi/ p1) was added and after 4 h, incorporation of radiolabeled thymidine determined as described above.
Results
Although the existence of a distinctive family of molecules designated trefoil peptides which in mammals are normally expressed almost exclusively in gastrointestinal mucosa and pancreas has been recognized, the physiological role(s) of these abundant constituents which appear to be differentially secreted Trefoil Peptides and Epithelial Restitution onto the mucosal surface have remained unclear. Some investigators have speculated that trefoil peptides may act fundamentally as growth factors, stimulating proliferation through interaction with cell surface receptors ( 18, 34, 35 ) . To test this hypothesis, the purified human trefoil peptide normally expressed in the proximal gastrointestinal tract HSP or semi-purified forms of the predominant trefoil peptide present in the small and large intestine ITF (rat and human) were added to subconfluent cultures of nontransformed rat intestinal epithelial cells (IEC-6 and IEC-17), human colon cancer-derived cell lines including those which retain the capacity to undergo phenotypic differentiation (CaCO2 and HT-29) (33), a human gastric cancer-derived cell line (AGS) and a rodent nontransformed fibroblast line (NRK). As shown in Table I , none of the trefoil peptides had a significant effect on the proliferation of any of these cell lines within the 24-h time frame assessed by incorporation of thymidine into acid precipitable material; previous studies in this laboratory have confirmed that the latter correlates directly with proliferation in the intestinal, colon cancer-derived and fibroblast lines. Trefoil peptides were evaluated over a range of concentrations from 0.1-1 jig/pl without significant stimulation or inhibition of proliferation; incorporation of thymidine remained within 22% of the untreated controls in all studies. In contrast, the intestinal derived cell lines IEC-6 and IEC-17 were highly sensitive to the growth inhibiting effect of TGFJ3I (> 90% inhibition at 5pM) and the growth stimulatory effects of TGFa ( > 100% stimulation at 0.1 jig/ml) used as comparative controls consistent with earlier observations in this laboratory and elsewhere (36) . The effect of the trefoil peptides on proliferation of the cell lines in the copresence of human or rat colonic mucin glycoproteins was also determined insofar as circumstantial observations suggest that these may be co-secreted onto the mucosal surface in vivo. However, the addition of these large molecular weight glycoproteins did not result in emergence of previously latent effects on proliferation by the trefoil peptides (data not shown).
Although the trefoil peptides had no significant effect on growth in a variety of cell lines derived from gastrointestinal tract epithelium, we speculated that these proteins secreted in abundance onto the mucosal surface might promote epithelial integrity in a manner distinct from typical peptide growth factors. Subsequently, we evaluated the effect of these peptides on restitution in an in vitro model of mucosal (epithelial) injury. A contact-inhibited confluent monolayer of IEC-6 cells was wounded in a standard fashion with a razor blade and migration into the defect to reconstitute the continuity of the monolayer was monitored. Previous studies have demonstrated that several cytokines and "classical" growth factors which may be present at the basolateral side of the epithelial surface monolayer in vivo enhance the rate of restitution in this model (29, 37-39). To determine whether trefoil peptides which are present at the apical surface in vivo might have a complementary role in promoting the reestablishment of epithelial integrity, the trefoil peptides alone or in combination with mucin glycoproteins were added to wounded IEC-6 cell monolayers.
As demonstrated in Figs. 1 and 2 , HSP enhanced the migration of IEC-6 cells into the wound approximately fourfold. No similar enhancement was seen when HSP was replaced with a nonspecific protein (BSA). Interestingly, the purified human mucin glycoprotein (HCGP) also enhanced restitution though to a lesser extent. However, the combined presence of HSP and HCGP led to a significant increase in the rate of restitution nal tract (small intestine) also stimulated restitution in this model in combination with HSP. These data suggest that the mucin glycoproteins may interact functionally with HSP as a reflection of structural features common to these glycoconjugates as a class. Subsequent experiments suggested that these observations may also reflect properties common to the family of trefoil peptides. Partially purified rat and human ITF, the trefoil peptide normally expressed in the small and large intestine, also stimulated restitution of wounded IEC-6 and IEC-17 monolayers. Promotion of migration by the two species of ITF was further enhanced by the copresence of colonic mucin glycoproteins (Fig. 4) . Collectively, these observations suggest that the ability to promote restitution, at least in this simplified in vitro model, is a property characteristic of the mammalian trefoil peptides as a family which may be enhanced through interaction with secreted mucin glycoproteins generally.
The relationship between rate of restitution in this in vitro model and the relative and absolute concentrations of trefoil peptides and mucin glycoproteins was explored through the assessment of migration following addition of varying amounts of HSP and HCGP. The limited quantities of ITFs precluded extending these studies to encompass these factors at this time. As demonstrated in Fig. 5 were produced by molecular cloning of full length cDNAs encoding these peptides into a baculovirus expression system and crude factor obtained in the media from transfected Sf9 cells. Wounds were established in confluent monolayers of IEC-6 as detailed in text and wounded monolayers cultured for 24 h after addition of control media or media containing RITF or HITF (10% vol/vol CM in serum deprived DME; estimated concentration 1 ug/lA) alone or in the presence of either RSIGP or HCGP (2 ,g/jA). Cells migrating across the wound margin as depicted in Fig. 1 , were quantitated by blinded determination of the number of cells/standard distance obtained in duplicate from each of two wells in at least three separate experiments. Results presented as mean +/-SD. *P < 0.001 compared with control; +P < 0.004 compared with RITF/HITF alone.
cytokines, anti-TGFB had no effect on the stimulation of restitution by HSP, HCGP, or the combination of HSP and HCGP (Fig. 6) . Subsequently, the effects of the trefoil peptides and mucin glycoprotein on production of TGFB peptide by the wounded monolayer were also assessed. As demonstrated in Fig. 7 , in contrast to the previously studied cytokines, neither HSP nor HCGP alone or in combination significantly altered the production of TGF,3 by the wounded monolayer. Addition of TGFB (1 pM) itself in the presence of HSP and HCGP function increased migration 28%±6% (not pictured). Collectively, these findings indicate that the trefoil peptides do not promote restitution through a TGFJ3-dependent pathway.
Discussion
The mucosal surface of the gastrointestinal tract forms an extended interface with the environment. Although the full complexity of the various host defenses present in the lamina propria has not been delineated, it is evident that the physical continuity of the surface epithelium and its barrier function are essential. In the normal mucosa, tight junctions between epithelial cells are especially important, preventing penetration of large molecular weight materials through paracellular pathways (42, 43 (44) (45) (46) (47) (48) . This process which has been observed after a variety of forms of mucosal injury in both the upper and lower gastrointestinal tract is remarkable for the rapidity through which even extensive surface ulceration may be re-epithelialized; Feil et al. (49) have demonstrated that fully 80% of the colonic surface area denuded by instillation of acetic acid will be recovered by the migration of epithelium within 4 h. Previous studies from this laboratory have demonstrated the capability of a number of cytokines and growth factors to promote restitution using a simplified in vitro model (29, 39) . These regulatory peptides which effect their actions through specific high-affinity cell surface receptors are produced by cellular constituents of the lamina propria especially in the context of cellular activation of inflammatory and immune response commonly seen after damage to the overlying epithelium (50) . These factors may be reasonably presumed to promote gastrointestinal tract epithelial migration through the basolateral pole. The studies described in this report suggest that the important process of restitution may also be promoted through the combined action of trefoil peptides and mucin glycoproteins. This complex would appear complementary to the previously identified mechanisms insofar as it is localized exclusively to the apical surface. The fundamental distinction between the restitution promoting effects through a TGF3-independent pathway, the mechanistic basis of this activity will be the focus of further studies.
Finally, the present study provides a new perspective on the functional role of trefoil peptides as a class. Despite an initial report of modest growth promoting effects of PSP when added to the media of some colon cancer-derived cell lines (18), we were unable to identify within the experimental conditions used in these studies any consistent stimulatory or inhibitory effect of any of the three trefoil peptides studied in a variety of cell lines. While it is possible that the lack of effect of the trefoil peptides could reflect the absence of suitable receptors, it is notable that one of these lines was responsive to the restitutionpromoting effects of these factors. Nonetheless, it is possible that trefoil factors could act as typical peptide growth factors in suitable target cells via receptors which are not involved in the pathway through which cell migration and restitution are mediated. In this context, it will be important to distinguish putative receptors from cell surface binding sites which might serve to anchor trefoil factors to the mucosal surface, perhaps complexed with mucin glycoproteins.
In addition, the present study suggests that trefoil peptides may share generic functional properties. Thus both HSP and ITF had comparable abilities to promote restitution of the IEC-6 intestinal epithelial cell line although the former peptide is normally found in the proximal gastrointestinal tract. We presume that the gastric trefoil factor pS2 would have similar effects on restitution, and conversely all of these trefoil factors would promote restitution in gastric epithelium as well. Further, the ability of both human and rodent trefoil peptides to enhance migration of the rodent line underscores the conserved functional properties of this family of peptides in the gastrointestinal tract. We also anticipate that the rodent trefoil peptide (or other mammalian and perhaps amphibian trefoil peptides) could similarly stimulate restitution in non-transformed human gastrointestinal epithelium.
In parallel, these studies indicate that the trefoil peptides possess a common structural basis for functional interaction with mucin glycoproteins broadly. Thus mucin glycoproteins from either rat or man appeared to function in a cooperative fashion with the rodent and human trefoil peptides. Similarly, mucin glycoproteins isolated from two different sites of the rat gastrointestinal tract functioned in an essentially comparable manner in their interaction with trefoil peptides to enhance restitution in the in vitro model. Although these studies have highlighted the interchangeable function of the trefoil peptides and mucin glycoproteins in the assays employed, insofar as the individual members of this family appear to have been evolutionarily conserved in a regionspecific manner, it is also reasonable to assume that each peptide possesses properties which may be specifically adapted to the sites of normal expression. These specific properties may include more exquisite specific interaction with site-specific mucin glycoproteins than could be resolved in the present model. Alternatively, these more specific features of the individual trefoil peptides and mucin glycoproteins could play a key role in functional properties of these substances in addition to their effects on restitution. While these studies have demonstrated the ability of trefoil peptides to promote restitution, it is possible that they also serve in other ways to protect the gastrointestinal tract mucosal integrity from damage.
